title: Effects of Delphinium alkaloids on neuromuscular transmission.
abstract: The Delphinium alkaloids methyllycaconitine (MLA), nudicauline, 14-deacetylnudicauline (14-DN), barbinine, and deltaline were investigated for their effects on neuromuscular transmission in lizards. The substituent at C14 provides the only structural difference among the alkaloids MLA, nudicauline, 14-DN, and barbinine. Deltaline lacks the N-(methylsuccinyl)anthranilic acid at C18 common to the other four alkaloids. Each alkaloid reversibly reduced extracellularly recorded compound muscle action potential (CMAP) amplitudes in a concentration-dependent manner. The IC(50) values for CMAP blockade were between 0.32 and 13.2 microM for the N-(methylsuccinimido)anthranoyllycacotonine-type alkaloids and varied with the C14 moiety; the IC(50) value for deltaline was 156 microM. The slopes of the concentration-response curves for CMAP blockade were similar for each alkaloid except barbinine, whose shallower curve suggested alternative or additional mechanisms of action. Each alkaloid reversibly reduced intracellularly recorded spontaneous, miniature end-plate potential (MEPP) amplitudes. Alkaloid concentrations producing similar reductions in MEPP amplitude were 0.05 microM for 14-DN, 0.10 microM for MLA, 0.50 microM for barbinine, and 20 microM for deltaline. Only barbinine altered the time constant for MEPP decay, further suggesting additional or alternative effects for this alkaloid. MLA and 14-DN blocked muscle contractions induced by exogenously added acetylcholine. All five alkaloids are likely nicotinic receptor antagonists that reduce synaptic efficacy and block neuromuscular transmission. The substituent at C14 determines the potency and possibly the mechanism of nicotinic acetylcholine receptor blockade for MLA, nudicauline, 14-DN, and barbinine at neuromuscular synapses. The lower potency of deltaline indicates that the N-(methylsuccinyl)anthranilic acid at C18 affects alkaloid interactions with nicotinic acetylcholine receptors at neuromuscular junctions.
authors.affiliation: Department of Anatomy and Neurobiology, Colorado State University, Fort Collins, Colorado 80523, USA.
authors.forename: P
authors.initials: P
authors.lastname: Dobelis
authors.forename: J E
authors.initials: JE
authors.lastname: Madl
authors.forename: J A
authors.initials: JA
authors.lastname: Pfister
authors.forename: G D
authors.initials: GD
authors.lastname: Manners
authors.forename: J P
authors.initials: JP
authors.lastname: Walrond
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000157:Aconitine / Q000031:analogs & derivatives / Q000633:toxicity; D000200:Action Potentials / Q000187:drug effects; D000470:Alkaloids / Q000633:toxicity*; D000818:Animals; D031882:Delphinium / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006614:Hindlimb / Q000187:drug effects; D066298:In Vitro Techniques; D007306:Insecticides / Q000633:toxicity*; D007366:Intercostal Muscles / Q000187:drug effects; D008116:Lizards / Q000502:physiology*; D009119:Muscle Contraction / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects*; D013997:Time Factors
chemical_list: D000470:Alkaloids; D007306:Insecticides; C054634:methyllycaconitine; D000109:Acetylcholine; D000157:Aconitine